Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.19 CNY
591.57 M CNY
6.65 B CNY
1.49 B
About ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD.
Sector
Headquarters
Hangzhou
Founded
1969
Website
ISIN
CNE000001H86
FIGI
BBG000MY5ZM3
Zhejiang Conba Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products. Its manufacturing division consists of modern herbal medicine, chemical drug, and biological drug production. Its products include traditional Chinese medicines, botanical extracts, chemical medicines and raw medicines, and health food. The company was founded in 1969 and is headquartered in Hangzhou, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 600572 is 4.77 CNY — it has decreased by −0.21% in the past 24 hours. Watch ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD. stocks are traded under the ticker 600572.
600572 stock has fallen by −2.25% compared to the previous week, the month change is a 4.15% rise, over the last year ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD. has showed a −11.01% decrease.
600572 reached its all-time high on Jul 23, 2015 with the price of 12.12 CNY, and its all-time low was 0.45 CNY and was reached on Jul 21, 2005. View more price dynamics on 600572 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
600572 stock is 1.69% volatile and has beta coefficient of 1.01. Track ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD. stock price on the chart and check out the list of the most volatile stocks — is ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD. there?
Yes, you can track ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD. financials in yearly and quarterly reports right on TradingView.
ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD. is going to release the next earnings report on Apr 18, 2025. Keep track of upcoming events with our Earnings Calendar.
600572 net income for the last quarter is 136.26 M CNY, while the quarter before that showed 166.14 M CNY of net income which accounts for −17.98% change. Track more ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD. financial stats to get the full picture.
Yes, 600572 dividends are paid annually. The last dividend per share was 0.20 CNY. As of today, Dividend Yield (TTM)% is 4.18%. Tracking ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD. dividends might help you take more informed decisions.
ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD. dividend yield was 3.96% in 2023, and payout ratio reached 86.88%. The year before the numbers were 3.17% and 107.68% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has 8.41 K employees. See our rating of the largest employees — is ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD. on this list?
Like other stocks, 600572 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD. stock shows the sell signal. See more of ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.